Latest News about MNKD
Recent news which mentions MNKD
Executives Buy Over $2.7M Of 4 Penny Stocks
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
From Benzinga
46 Biggest Movers From Yesterday
October 19, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher
October 18, 2021
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
October 18, 2021
From Benzinga
Why Shares of MannKind Corporation Are Falling This Morning
October 18, 2021
From Motley Fool
From Benzinga
34 Stocks Moving In Monday's Mid-Day Session
October 18, 2021
From Benzinga
The FuelCell Energy Chatter That Has FCEL Stock Trending Today
October 18, 2021
From InvestorPlace
From InvestorPlace
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease
October 18, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 18, 2021
From Benzinga
From InvestorPlace
10 momentum stocks that are entering a favorable stage of the year
October 08, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 29, 2021
From Benzinga
United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients
September 07, 2021
From Benzinga
The 6 Best Penny Stocks to Buy for September
August 30, 2021
From InvestorPlace
MannKind Corporation (MNKD) Q2 2021 Earnings Call Transcript
August 12, 2021
Tickers
MNKD
From Motley Fool
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.